Evidence map›Paper›PMID 30532064›Full record

ArticleScientific reports2018

Triple lead cephalic versus subclavian vein approach in cardiac resynchronization therapy device implantation.

Julia Vogler, Anne Geisler, Nils Gosau, Samer Hakmi, Stephan Willems, Tienush Rassaf, Reza Wakili, Elif Kaya

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Venous access routes for cardiac implantable electronic devices].Herzschrittmachertherapie & Elektrophysiologie · 2023
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia VoglerDepartment of Electrophysiology, University Heart Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.
Anne GeislerDepartment of Electrophysiology, University Heart Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.
Nils GosauDepartment of Electrophysiology, University Heart Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.
Samer HakmiDepartment of Cardiovascular Surgery, University Heart Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.
Stephan WillemsDepartment of Electrophysiology, University Heart Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.
Tienush RassafDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.
Reza WakiliDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany. reza.wakili@uk-essen.de.
Elif KayaDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac resynchronization therapy (CRT) device implantation is associated with severe complications including pneumo- and hemothorax. Data on a sole cephalic vein approach (sCV), potentially preventing these complications, are limited. The aim of our study was to compare a sole cSV with a subclavian vein approach (SV) in CRT implantations with respect to feasibility and safety. We performed a prospective cohort study enrolling twenty-four consecutive de-novo CRT implantations (group A) using a sCV at two centers. Fifty-four age-matched CRT patients implanted via the SV served (group B) as reference. Procedural success rate and complications were recorded during a follow-up of 4 weeks. All CRTs could be implanted in group A, with 91.7% using cephalic access alone. In group B, CRT implantation was successfully performed in 96.3%. Procedure and fluoroscopy duration were similar for both groups (sCV vs. SV: 119 ± 45 vs. 106 ± 31 minutes, 17 ± 9 vs 14 ± 9 minutes). Radiation dosage was higher in sCV group vs. SV (2984 ± 2370 vs. 1580 ± 1316 cGy*cm

Indexed as

AgedCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesFeasibility StudiesFemaleHumansMaleProspective StudiesProsthesis ImplantationSubclavian VeinTreatment Outcome

Identifiers

PMID30532064
PMCPMC6286359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.